BiotechTube

Measles vaccine

ApprovedCompleted
1 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Measles

Conditions

Measles, Diphtheria, Tetanus, Pertussis

Trial Timeline

Jan 1, 2006 → Jan 1, 2007

NCT ID
NCT00168545

About Measles vaccine

Measles vaccine is a approved stage product being developed by Novo Nordisk for Measles. The current trial status is completed. This product is registered under clinical trial identifier NCT00168545. Target conditions include Measles, Diphtheria, Tetanus.

What happened to similar drugs?

3 of 17 similar drugs in Measles were approved

Approved (3) Terminated (1) Active (13)
🔄Measles-Rubella vaccine (Live) I.P. (Freeze Dried) of M/s. Zydus Lifesciences Ltd + Yellow fever Vaccine (WHO prequalified)Zydus LifesciencesPhase 3
🔄MMRV (AMP) + MMRV (2006 process)MerckPhase 3
🔄M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX®MerckPhase 3
❌Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (ProQuad™) + M-M-R™ II and Varivax™MerckPhase 3
🔄Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Varivax + Comparator: M-M-R IIMerckPhase 3
🔄ProQuad® manufactured with recombinant Human Albumin (rHA)MerckPhase 3
🔄Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live + Comparator: VARIVAX(TM) Varicella Virus Vaccine Live (Oka-Merck)MerckPhase 3

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (3)

NCT IDPhaseStatus
NCT00168545ApprovedCompleted
NCT00168558ApprovedCompleted
NCT00168571ApprovedCompleted

Competing Products

20 competing products in Measles

See all competitors
ProductCompanyStageHype Score
Measles-Rubella vaccine (Live) I.P. (Freeze Dried) of M/s. Zydus Lifesciences Ltd + Yellow fever Vaccine (WHO prequalified)Zydus LifesciencesPhase 3
47
MMRV (AMP) + MMRV (2006 process)MerckPhase 3
40
M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX®MerckPhase 3
40
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (ProQuad™) + M-M-R™ II and Varivax™MerckPhase 3
32
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: M-M-R II + Comparator: PUVVMerckPhase 2
35
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Varivax + Comparator: M-M-R IIMerckPhase 3
40
ProQuad® manufactured with recombinant Human Albumin (rHA)MerckPhase 3
40
Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live + Comparator: VARIVAX(TM) Varicella Virus Vaccine Live (Oka-Merck)MerckPhase 3
40
measles, mumps, and rubella virus vaccine live + Comparator: Measles, Mumps, and Rubella Virus Vaccine LiveMerckPhase 2
35
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Tripedia + Comparator: Comvax + Comparator: Varivax + Comparator: M-M-R IIMerckPhase 3
40
V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live / Duration of Treatment: 12 weeksMerckPhase 3
40
V205C, measles, mumps, and rubella virus vaccine live + Comparator: Measles, Mumps, and Rubella Virus Vaccine LiveMerckPhase 2
35
Comparator: ProQuad™ (V221) + Comparator: PREVNAR™ (pneumococcal 7-valent conjugate vaccine)MerckPhase 3
40
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Placebo + Comparator: Varivax + Comparator: M-M-R IIMerckPhase 3
40
ProQuad®MerckPhase 3
40
MMR vaccineMerckPre-clinical
26
ProQuad®MerckPhase 3
40
ProQuad (Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live) + Comparator: M-M-R II + Comparator: Varivax + Comparator: PlaceboMerckPhase 3
40
Measles vaccineNovo NordiskApproved
43
Measles vaccineNovo NordiskApproved
43